# WHITNEY ECONOMICS FORECASTS U.S. CANNABIS GROWTH TO RESUME IN 2026

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/cannabis-market-growth-2026-whitney-economics-forecast/
> **Published:** 2026-03-24T21:02:02-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:57-04:00
> **Clinical Summary:** Whitney Economics forecasts cannabis market growth 2026, impacting patient access, industry trends, and regulatory changes in the U.S. cannabis sector.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Market AccessPatient AccessIndustry TrendsTreatment Planning[Healthcare Economics](https://cedclinic.com/cannabis-industry-medical-neglect-market-patient-impact/)

Why This Matters

Market forecasting influences patient access, product availability, and treatment continuity. Understanding industry trends helps clinicians anticipate changes in product formulations, pricing, and regulatory frameworks that directly impact [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) decisions.

Clinical Summary
Whitney Economics projects renewed growth in the U.S. cannabis market beginning in 2026, following a period of market contraction. The forecast suggests stabilization after industry consolidation and regulatory maturation. Market dynamics affect product development, quality control standards, and patient access patterns across different therapeutic applications.

Dr. Caplan’s Take

“Market predictions don’t change the medicine, but they do influence what products my patients can access and afford. I watch these trends to anticipate supply disruptions and guide patients toward sustainable treatment approaches.”

Clinical Perspective
🧠 Clinicians should monitor how market changes affect their patients’ access to consistent formulations and dosing. Consider discussing treatment plan flexibility with patients, particularly those on specialized products that may face availability or pricing changes during market transitions.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20WHITNEY%20ECONOMICS%20FORECASTS%20U.S.%20CANNABIS%20GROWTH%20TO%20RESUME%20IN%202026%20%40drcaplan&url=https%3A//whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%25C2%25A0)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%25C2%25A0)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20WHITNEY%20ECONOMICS%20FORECASTS%20U.S.%20CANNABIS%20GROWTH%20TO%20RESUME%20IN%202026%20--%20via%20%40drcaplan.bsky.social%20https%3A//whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%25C2%25A0)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%C2%A0](https://whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%C2%A0)

Table of Contents

- [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news)
- [What key areas does this cannabis clinical update cover?](#What_key_areas_does_this_cannabis_clinical_update_cover)
- [Why is this information considered clinically relevant?](#Why_is_this_information_considered_clinically_relevant)
- [What type of healthcare professionals should pay attention to this update?](#What_type_of_healthcare_professionals_should_pay_attention_to_this_update)
- [How does this relate to current medical cannabis practice?](#How_does_this_relate_to_current_medical_cannabis_practice)
- [Related](#Related)

## FAQ

#### What is the clinical relevance rating of this cannabis news?

This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely.

#### What key areas does this cannabis clinical update cover?

The update focuses on four main areas: Market Access, Patient Access, Industry Trends, and Treatment Planning. These categories indicate comprehensive coverage of both clinical and practical aspects of [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/).

#### Why is this information considered clinically relevant?

The content addresses emerging findings or policy developments in the cannabis field that warrant close monitoring by healthcare professionals. This suggests potential implications for [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) or treatment protocols.

#### What type of healthcare professionals should pay attention to this update?

This information is particularly relevant for clinicians involved in [medical cannabis treatment](https://cedclinic.com/medical-cannabis-eligibility-book-appointment/) planning and patient care. Healthcare providers interested in cannabis therapeutics, policy changes, and patient access issues should monitor these developments.

#### How does this relate to current medical cannabis practice?

The focus on treatment planning and patient access suggests this update contains information that could directly impact clinical decision-making. The industry trends component also indicates potential changes in available treatment options or delivery methods.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “WHITNEY ECONOMICS FORECASTS U.S. CANNABIS GROWTH TO RESUME IN 2026”, “url”: “https://whitneyeconomics.com/press-detail/whitney-economics-forecasts-u.s.-cannabis-growth-to-resume-in-2026-%C2%A0”, “datePublished”: “2026-03-24T23:22:54Z”, “about”: “whitney economics forecasts u s cannabis”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Five Takeaways from the Global Medical Cannabis Market Review 2026](https://cedclinic.com/global-medical-cannabis-market-review-2026-insights/)

Explore key insights from the global [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) market in 2026, highlighting trends that shape patient access and industry growth.

[Read More](https://cedclinic.com/global-medical-cannabis-market-review-2026-insights/)

The Week Ahead (March 23, 2026) – Cannabis Observer

Stay updated with upcoming cannabis market developments and regulatory changes expected in 2026.

View Updates

[Cannabis Industry Statistics – Pennsylvania Institute of Technology](https://cedclinic.com/cannabis-industry-statistics-pennsylvania/)

Review comprehensive [cannabis industry](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) statistics to understand market dynamics and patient access trends.

[Explore Statistics](https://cedclinic.com/cannabis-industry-statistics-pennsylvania/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).